Global Covid-19 Therapeutic Market Size, Status and Forecast 2024-2031

Report ID: 922157 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Covid-19 Therapeutic Market Size Growth Rate by Type (2021-2027)
        1.2.2 Immunotherapy
        1.2.3 Life Support
        1.2.4 Antiviral Medicine
        1.2.5 Plasma Therapy
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Covid-19 Therapeutic Market Share by Application (2021-2027)
        1.3.2 Children
        1.3.3 Adult
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Covid-19 Therapeutic Market Size
     2.2 Covid-19 Therapeutic Market Size by Regions
        2.2.1 Covid-19 Therapeutic Growth Rate by Regions (2021-2027)
        2.2.2 Covid-19 Therapeutic Market Share by Regions (2021-2027)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Use Cases

3 Key Players
    3.1 Covid-19 Therapeutic Revenue by Players (2020-2021)
    3.2 Covid-19 Therapeutic Key Players Headquaters and Area Served
    3.3 Key Players Covid-19 Therapeutic Product/Solution/Service
    3.4 Date of Enter into Covid-19 Therapeutic Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
    4.1 Global Covid-19 Therapeutic Market Size by Type (2021-2027)
    4.2 Global Covid-19 Therapeutic Market Size by Application (2021-2027)

5 North America
   5.1 North America Covid-19 Therapeutic Market Forecast (2021-2027)
    5.2 Covid-19 Therapeutic Key Players in North America
    5.3 North America Covid-19 Therapeutic Market Size by Type
    5.4 North America Covid-19 Therapeutic Market Size by Application
        6.4.4 Canada

6 Europe
    6.1 Europe Covid-19 Therapeutic Market Forecast (2021-2027)
    6.2 Covid-19 Therapeutic Key Players in Europe
    6.3 Europe Covid-19 Therapeutic Market Size by Type
    6.4 Europe Covid-19 Therapeutic Market Size by Application

7 Japan
    7.1 Japan Covid-19 Therapeutic Market Forecast (2021-2027)
    7.2 Covid-19 Therapeutic Key Players in Europe
    7.3 Japan Covid-19 Therapeutic Market Size by Type
    7.4 Japan Covid-19 Therapeutic Market Size by Application

8 Rest of World
    8.1 China
        8.1.1 China Covid-19 Therapeutic Market Analysis
        8.1.2 Key Players in China
    8.2 Southeast Asia
        8.2.1 Southeast Asia Covid-19 Therapeutic Market Analysis
        8.2.2 Key Players in Southeast Asia
    8.3 India
        8.3.1 India Covid-19 Therapeutic Market Analysis
        8.3.2 Key Players in India


9 International Player Profiles
    9.1 Cadila Healthcare
        9.1.1 Cadila Healthcare Company Details
        9.1.2 Cadila Healthcare Description and Business Overview
        9.1.3 Cadila Healthcare Covid-19 Therapeutic Introduction
        9.1.4 Cadila Healthcare Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.1.5 Cadila Healthcare Recent Development
    9.2 Johnson & Johnson
        9.2.1 Johnson & Johnson Company Details
        9.2.2 Johnson & Johnson Description and Business Overview
        9.2.3 Johnson & Johnson Covid-19 Therapeutic Introduction
        9.2.4 Johnson & Johnson Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.2.5 Johnson & Johnson Recent Development
    9.3 ImmunoPrecise
        9.3.1 ImmunoPrecise Company Details
        9.3.2 ImmunoPrecise Description and Business Overview
        9.3.3 ImmunoPrecise Covid-19 Therapeutic Introduction
        9.3.4 ImmunoPrecise Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.3.5 ImmunoPrecise Recent Development
    9.4 Novartis
        9.4.1 Novartis Company Details
        9.4.2 Novartis Description and Business Overview
        9.4.3 Novartis Covid-19 Therapeutic Introduction
        9.4.4 Novartis Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.4.5 Novartis Recent Development
    9.5 AstraZeneca
        9.5.1 AstraZeneca Company Details
        9.5.2 AstraZeneca Description and Business Overview
        9.5.3 AstraZeneca Covid-19 Therapeutic Introduction
        9.5.4 AstraZeneca Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.5.5 AstraZeneca Recent Development
    9.6 Cipla
        9.6.1 Cipla Company Details
        9.6.2 Cipla Description and Business Overview
        9.6.3 Cipla Covid-19 Therapeutic Introduction
        9.6.4 Cipla Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.6.5 Cipla Recent Development
    9.7 AbbVie
        9.7.1 AbbVie Company Details
        9.7.2 AbbVie Description and Business Overview
        9.7.3 AbbVie Covid-19 Therapeutic Introduction
        9.7.4 AbbVie Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.7.5 AbbVie Recent Development
    9.8 Bayer
        9.8.1 Bayer Company Details
        9.8.2 Bayer Description and Business Overview
        9.8.3 Bayer Covid-19 Therapeutic Introduction
        9.8.4 Bayer Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.8.5 Bayer Recent Development
    9.9 Regeneron Pharmaceuticals
        9.9.1 Regeneron Pharmaceuticals Company Details
        9.9.2 Regeneron Pharmaceuticals Description and Business Overview
        9.9.3 Regeneron Pharmaceuticals Covid-19 Therapeutic Introduction
        9.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.9.5 Regeneron Pharmaceuticals Recent Development
    9.10 Ascletis Pharma
        9.10.1 Ascletis Pharma Company Details
        9.10.2 Ascletis Pharma Description and Business Overview
        9.10.3 Ascletis Pharma Covid-19 Therapeutic Introduction
        9.10.4 Ascletis Pharma Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.10.5 Ascletis Pharma Recent Development
    9.11 GlaxoSmithKline
        9.11.1 GlaxoSmithKline Company Details
        9.11.2 GlaxoSmithKline Description and Business Overview
        9.11.3 GlaxoSmithKline Covid-19 Therapeutic Introduction
        9.11.4 GlaxoSmithKline Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.11.5 GlaxoSmithKline Recent Development
    9.12 Gilead Sciences
        9.12.1 Gilead Sciences Company Details
        9.12.2 Gilead Sciences Description and Business Overview
        9.12.3 Gilead Sciences Covid-19 Therapeutic Introduction
        9.12.4 Gilead Sciences Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.12.5 Gilead Sciences Recent Development
    9.13 Pharmstandard
        9.13.1 Pharmstandard Company Details
        9.13.2 Pharmstandard Description and Business Overview
        9.13.3 Pharmstandard Covid-19 Therapeutic Introduction
        9.13.4 Pharmstandard Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.13.5 Pharmstandard Recent Development
    9.14 Fujifilm Holdings
        9.14.1 Fujifilm Holdings Company Details
        9.14.2 Fujifilm Holdings Description and Business Overview
        9.14.3 Fujifilm Holdings Covid-19 Therapeutic Introduction
        9.14.4 Fujifilm Holdings Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.14.5 Fujifilm Holdings Recent Development
    9.15 Zhejiang Hisun Pharmaceutical Co. Ltd
        9.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
        9.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Description and Business Overview
        9.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Introduction
        9.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
    9.16 Roche
        9.16.1  Company Details
        9.16.2 Roche Description and Business Overview
        9.16.3 Roche Covid-19 Therapeutic Introduction
        9.16.4 Roche Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.16.5 Roche Recent Development
    9.17 Sanofi
        9.17.1 Sanofi Company Details
        9.17.2 Sanofi Description and Business Overview
        9.17.3 Sanofi Covid-19 Therapeutic Introduction
        9.17.4 Sanofi Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.17.5 Sanofi Recent Development
    9.18 Pfizer
        9.18.1 Pfizer Company Details
        9.18.2 Pfizer Description and Business Overview
        9.18.3 Pfizer Covid-19 Therapeutic Introduction
        9.18.4 Pfizer Revenue in Covid-19 Therapeutic Business (2020-2021)
        9.18.5 Pfizer Recent Development

10 Market Dynamics
    10.1 Industry Trends
    10.2 Market Drives
    10.3 Market Challenges
    10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
        12.1.2 Data Source
    12.2 Disclaimer
    12.3 Author Details
List of Tables
    Table 1. Global Covid-19 Therapeutic Market Size Growth Rate by Type (2021-2027) (US$ Million)
    Table 2. Key Players of Immunotherapy
    Table 3. Key Players of Life Support
    Table 4. Key Players of Antiviral Medicine
    Table 5. Key Players of Plasma Therapy
    Table 6. Key Players of Others
    Table 7. Global Covid-19 Therapeutic Market Size Growth by Application (2021-2027) (US$ Million)
    Table 8. Global Covid-19 Therapeutic Market Size by Regions (2021-2027) (US$ Million)
    Table 9. Global Covid-19 Therapeutic Market Share by Regions (2021-2027)
    Table 10. Market Top Trends
    Table 11. Market Use Cases
    Table 12. Global Covid-19 Therapeutic Revenue by Players (2020-2021) (US$ Million)
    Table 13. Global Covid-19 Therapeutic Market Share by Players (2020-2021)
    Table 14. Key Players Headquarters and Area Served
    Table 15. Key Players Covid-19 Therapeutic Product Solution and Service
    Table 16. Date of Enter into Covid-19 Therapeutic Market
    Table 17. Mergers & Acquisitions, Expansion Plans
    Table 18. Global Covid-19 Therapeutic Market Size by Type (2021-2027) (US$ Million)
    Table 19. Global Covid-19 Therapeutic Market Size Share by Type (2021-2027)
    Table 20. Global Covid-19 Therapeutic Market Size by Application (2021-2027) (US$ Million)
    Table 21. Global Covid-19 Therapeutic Market Size Share by Application (2021-2027)
    Table 22. North America Key Players Covid-19 Therapeutic Revenue (2020-2021) (US$ Million)
    Table 23. North America Key Players Covid-19 Therapeutic Market Share (2020-2021)
    Table 24. North America Covid-19 Therapeutic Market Size by Type (2021-2027) (US$ Million)
    Table 25. North America Covid-19 Therapeutic Market Share by Type (2021-2027)
    Table 26. North America Covid-19 Therapeutic Market Size by Application (2021-2027) (US$ Million)
    Table 27. North America Covid-19 Therapeutic Market Share by Application (2021-2027)
    Table 28. Europe Key Players Covid-19 Therapeutic Revenue (2020-2021) (US$ Million)
    Table 29. Europe Key Players Covid-19 Therapeutic Market Share (2020-2021)
    Table 30. Europe Covid-19 Therapeutic Market Size by Type (2021-2027) (US$ Million)
    Table 31. Europe Covid-19 Therapeutic Market Share by Type (2021-2027)
    Table 32. Europe Covid-19 Therapeutic Market Size by Application (2021-2027) (US$ Million)
    Table 33. Europe Covid-19 Therapeutic Market Share by Application (2021-2027)
    Table 34. Japan Key Players Covid-19 Therapeutic Revenue (2020-2021) (US$ Million)
    Table 35. Japan Key Players Covid-19 Therapeutic Market Share (2020-2021)
    Table 36. Japan Covid-19 Therapeutic Market Size by Type (2021-2027) (US$ Million)
    Table 37. Japan Covid-19 Therapeutic Market Share by Type (2021-2027)
    Table 38. Japan Covid-19 Therapeutic Market Size by Application (2021-2027) (US$ Million)
    Table 39. Japan Covid-19 Therapeutic Market Share by Application (2021-2027)
    Table 40. Key Players in China
    Table 41. Key Players in Southeast Asia
    Table 42. Key Players in India
    Table 43. Cadila Healthcare Company Details
    Table 44. Cadila Healthcare Description and Business Overview
    Table 45. Cadila Healthcare Covid-19 Therapeutic Product
    Table 46. Cadila Healthcare Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 47. Cadila Healthcare Recent Development
    Table 48. Johnson & Johnson Company Details
    Table 49. Johnson & Johnson Description and Business Overview
    Table 50. Johnson & Johnson Covid-19 Therapeutic Product
    Table 51. Johnson & Johnson Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 52. Johnson & Johnson Recent Development
    Table 53. ImmunoPrecise Company Details
    Table 54. ImmunoPrecise Description and Business Overview
    Table 55. ImmunoPrecise Covid-19 Therapeutic Product
    Table 56. ImmunoPrecise Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 57. ImmunoPrecise Recent Development
    Table 58. Novartis Company Details
    Table 59. Novartis Description and Business Overview
    Table 60. Novartis Covid-19 Therapeutic Product
    Table 61. Novartis Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 62. Novartis Recent Development
    Table 63. AstraZeneca Company Details
    Table 64. AstraZeneca Description and Business Overview
    Table 65. AstraZeneca Covid-19 Therapeutic Product
    Table 66. AstraZeneca Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 67. AstraZeneca Recent Development
    Table 68. Cipla Company Details
    Table 69. Cipla Description and Business Overview
    Table 70. Cipla Covid-19 Therapeutic Product
    Table 71. Cipla Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 72. Cipla Recent Development
    Table 73. AbbVie Company Details
    Table 74. AbbVie Description and Business Overview
    Table 75. AbbVie Covid-19 Therapeutic Product
    Table 76. AbbVie Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 77. AbbVie Recent Development
    Table 78. Bayer Company Details
    Table 79. Bayer Description and Business Overview
    Table 80. Bayer Covid-19 Therapeutic Product
    Table 81. Bayer Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 82. Bayer Recent Development
    Table 83. Regeneron Pharmaceuticals Company Details
    Table 84. Regeneron Pharmaceuticals Description and Business Overview
    Table 85. Regeneron Pharmaceuticals Covid-19 Therapeutic Product
    Table 86. Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 87. Regeneron Pharmaceuticals Recent Development
    Table 88. Ascletis Pharma Company Details
    Table 89. Ascletis Pharma Description and Business Overview
    Table 90. Ascletis Pharma Covid-19 Therapeutic Product
    Table 91. Ascletis Pharma Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 92. Ascletis Pharma Recent Development
    Table 93. GlaxoSmithKline Company Details
    Table 94. GlaxoSmithKline Description and Business Overview
    Table 95. GlaxoSmithKline Covid-19 Therapeutic Product
    Table 96. GlaxoSmithKline Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 97. GlaxoSmithKline Recent Development
    Table 98. Gilead Sciences Company Details
    Table 99. Gilead Sciences Description and Business Overview
    Table 100. Gilead Sciences Covid-19 Therapeutic Product
    Table 101. Gilead Sciences Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 102. Gilead Sciences Recent Development
    Table 103. Pharmstandard Company Details
    Table 104. Pharmstandard Description and Business Overview
    Table 105. Pharmstandard Covid-19 Therapeutic Product
    Table 106. Pharmstandard Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 107. Pharmstandard Recent Development
    Table 108. Fujifilm Holdings Company Details
    Table 109. Fujifilm Holdings Description and Business Overview
    Table 110. Fujifilm Holdings Covid-19 Therapeutic Product
    Table 111. Fujifilm Holdings Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 112. Fujifilm Holdings Recent Development
    Table 113. Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
    Table 114. Zhejiang Hisun Pharmaceutical Co. Ltd Description and Business Overview
    Table 115. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Product
    Table 116. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 117. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
    Table 118. Roche Company Details
    Table 119. Roche Description and Business Overview
    Table 120. Roche Covid-19 Therapeutic Product
    Table 121. Roche Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 122. Roche Recent Development
    Table 123. Sanofi Company Details
    Table 124. Sanofi Description and Business Overview
    Table 125. Sanofi Covid-19 Therapeutic Product
    Table 126. Sanofi Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 127. Sanofi Recent Development
    Table 128. Pfizer Company Details
    Table 129. Pfizer Description and Business Overview
    Table 130. Pfizer Covid-19 Therapeutic Product
    Table 131. Pfizer Revenue in Covid-19 Therapeutic Business 2020 and 2021
    Table 132. Pfizer Recent Development
    Table 133. Covid-19 Therapeutic Market Trends
    Table 134. Covid-19 Therapeutic Market Drivers
    Table 135. Covid-19 Therapeutic Market Challenges
    Table 136. Covid-19 Therapeutic Market Restraints
    Table 137. Research Programs/Design for This Report
    Table 138. Key Data Information from Secondary Sources
    Table 139. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Covid-19 Therapeutic Market Share by Type in 2021 & 2027
    Figure 2. Immunotherapy Features
    Figure 3. Life Support Features
    Figure 4. Antiviral Medicine Features
    Figure 5. Plasma Therapy Features
    Figure 6. Others Features
    Figure 7. Global Covid-19 Therapeutic Market Share by Application in 2021 & 2027
    Figure 8. Children Case Studies
    Figure 9. Adult Case Studies
    Figure 10. Covid-19 Therapeutic Report Years Considered
    Figure 11. Global Covid-19 Therapeutic Market Size and Growth Rate (2020-2027) (US$ Million)
    Figure 12. Global Covid-19 Therapeutic Market Share by Regions (2020-2027)
    Figure 13. Global Covid-19 Therapeutic Market Share by Players in 2021
    Figure 14. Global Covid-19 Therapeutic Market Size Market Share by Type (2021-2027)
    Figure 15. Global Covid-19 Therapeutic Market Size Market Share by Application (2021-2027)
    Figure 16. Global Covid-19 Therapeutic Revenue Market Share by Application in 2021
    Figure 17. North America Covid-19 Therapeutic Market Size 2021-2027 (US$ Million)
    Figure 18. Europe Covid-19 Therapeutic Market Size 2021-2027 (US$ Million)
    Figure 19. Japan Covid-19 Therapeutic Market Size 2021-2027 (US$ Million)
    Figure 20. Covid-19 Therapeutic Market Size in China (2021-2027) (US$ Million)
    Figure 21. Covid-19 Therapeutic Market Size in Southeast Asia (2021-2027) (US$ Million)
    Figure 22. Covid-19 Therapeutic Market Size in India (2021-2027) (US$ Million)
    Figure 23. Bottom-up and Top-down Approaches for This Report
    Figure 24. Data Triangulation
    Figure 25. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Frequently Asked Questions
Covid-19 Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Covid-19 Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Covid-19 Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Drug Reprofiling

Market Analysis and Insights: Global Drug Reprofiling Market
The global Drug Reprof ... Read More